These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27039606)

  • 1. [Magnesium: the missing link between kidneys and vessels?].
    Tran TA; Jaques D; Ponte B
    Rev Med Suisse; 2016 Feb; 12(507):404-7. PubMed ID: 27039606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation.
    Dousdampanis P; Trigka K; Fourtounas C
    Hemodial Int; 2014 Oct; 18(4):730-9. PubMed ID: 24641780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
    Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
    Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium and cardiovascular complications of chronic kidney disease.
    Massy ZA; Drüeke TB
    Nat Rev Nephrol; 2015 Jul; 11(7):432-42. PubMed ID: 25963594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium in chronic kidney disease: challenges and opportunities.
    Kanbay M; Goldsmith D; Uyar ME; Turgut F; Covic A
    Blood Purif; 2010; 29(3):280-92. PubMed ID: 20090315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis.
    Sakaguchi Y; Fujii N; Shoji T; Hayashi T; Rakugi H; Isaka Y
    Kidney Int; 2014 Jan; 85(1):174-81. PubMed ID: 23986148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is lipid management effective for all stages of CKD?
    Ku E; Campese V
    Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting magnesium status to enhance clinical care: key indicators.
    Costello RB; Nielsen F
    Curr Opin Clin Nutr Metab Care; 2017 Nov; 20(6):504-511. PubMed ID: 28806179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?
    Leenders NHJ; Vervloet MG
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium in chronic kidney disease: unanswered questions.
    Spiegel DM
    Blood Purif; 2011; 31(1-3):172-6. PubMed ID: 21228586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease.
    Van Laecke S; Nagler EV; Verbeke F; Van Biesen W; Vanholder R
    Am J Med; 2013 Sep; 126(9):825-31. PubMed ID: 23891286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.
    Muñoz-Castañeda JR; Pendón-Ruiz de Mier MV; Rodríguez M; Rodríguez-Ortiz ME
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF23: a mature renal and cardiovascular risk factor?
    Zoccali C; Yilmaz MI; Mallamaci F
    Blood Purif; 2013; 36(1):52-7. PubMed ID: 23735695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors are associated with lower magnesium levels in older people with chronic kidney disease.
    Sumukadas D; McMurdo ME; Habicht D
    J Am Geriatr Soc; 2012 Feb; 60(2):392-3. PubMed ID: 22332695
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.
    Khatami MR; Mirchi E; Khazaeipour Z; Abdollahi A; Jahanmardi A
    Iran J Kidney Dis; 2013 Jan; 7(1):47-52. PubMed ID: 23314142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cardiovascular mortality in chronic kidney disease (CKD) patients.
    Sun W; Liu D; Gong P; Shi X; Wang Y; Wang P; Gong W
    Ann Transplant; 2014 Oct; 19():513-8. PubMed ID: 25315215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum magnesium concentration is inversely associated with fibroblast growth factor 23 in haemodialysis patients.
    Iguchi A; Watanabe Y; Iino N; Kazama JJ; Iesato H; Narita I
    Nephrology (Carlton); 2014 Nov; 19(11):667-71. PubMed ID: 24899171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium and the risk of all-cause and cardiac mortality in hemodialysis patients: agent provocateur or innocent bystander?
    Courivaud C; Davenport A
    Kidney Int; 2014 Jan; 85(1):17-20. PubMed ID: 24380904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects.
    Altura BM; Altura BT
    Magnesium; 1985; 4(5-6):226-44. PubMed ID: 3914580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomagnesaemia, the kidney and the vessels.
    Van Laecke S; Van Biesen W; Vanholder R
    Nephrol Dial Transplant; 2012 Nov; 27(11):4003-10. PubMed ID: 22610987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.